Anne E Dixon1, Elizabeth A Sugar2, S James Zinreich2, Raymond G Slavin3, Jonathan Corren4, Robert M Naclerio5, Masaru Ishii2, Rubin I Cohen6, Ellen D Brown2, Robert A Wise2, Charles G Irvin7. 1. Department of Medicine, University of Vermont, Burlington, VT. Electronic address: anne.dixon@uvm.edu. 2. Johns Hopkins University, Baltimore, MD. 3. Saint Louis University, St. Louis, MO. 4. University of California Los Angeles, Los Angeles, CA. 5. Department of Surgery, University of Chicago, Chicago, IL. 6. Department of Pulmonary and Sleep Medicine, North Shore-Long Island Jewish Medical Center, New Hyde Park, NY. 7. Department of Medicine, University of Vermont, Burlington, VT.
Abstract
BACKGROUND: Sinusitis and rhinitis are associated with uncontrolled asthma. There are no simple, validated tools to screen for these diseases. The objective of this study was to assess instruments to assist in the diagnosis of chronic sinonasal disease. METHODS: Participants without acute sinonasal symptoms underwent an extensive evaluation. The results were submitted to an expert panel that used the Delphi method to achieve consensus. Using the consensus diagnosis of the panel, we determined the sensitivity and specificity of test procedures to diagnose chronic sinonasal disease. We determined the reproducibility of the most sensitive and specific instrument in a separate cohort. RESULTS: Fifty-nine participants were evaluated, and the expert panel reached consensus for all (42 participants with chronic sinonasal disease, 17 participants without chronic sinonasal disease). A six-item questionnaire based on the frequency of nasal symptoms was the most sensitive tool used to diagnose sinonasal disease (minimum specificity, 0.90). Reproducibility testing in a separate cohort of 63 participants (41 chronic sinonasal disease with asthma, 22 chronic sinonasal disease without asthma) showed a concordance correlation coefficient of 0.91 (95% CI, 0.85 to 0.94) when this questionnaire was limited to five items (ie, excluding a question on smell). This five-item questionnaire had a sensitivity of 0.90 (95% CI, 0.77 to 0.97), a specificity of 0.94 (95% CI, 0.71 to 1.00), and an area under the receiver operating characteristic curve of 0.97 (95% CI, 0.93 to 1.0). Sinus CT scans and nasal endoscopy lacked sensitivity for use in the diagnosis of chronic sinonasal disease. CONCLUSIONS: We have developed a sensitive, specific, and reproducible instrument to screen for chronic sinonasal disease. Validation studies of this five-item questionnaire are needed, including in patients with asthma.
BACKGROUND:Sinusitis and rhinitis are associated with uncontrolled asthma. There are no simple, validated tools to screen for these diseases. The objective of this study was to assess instruments to assist in the diagnosis of chronic sinonasal disease. METHODS:Participants without acute sinonasal symptoms underwent an extensive evaluation. The results were submitted to an expert panel that used the Delphi method to achieve consensus. Using the consensus diagnosis of the panel, we determined the sensitivity and specificity of test procedures to diagnose chronic sinonasal disease. We determined the reproducibility of the most sensitive and specific instrument in a separate cohort. RESULTS: Fifty-nine participants were evaluated, and the expert panel reached consensus for all (42 participants with chronic sinonasal disease, 17 participants without chronic sinonasal disease). A six-item questionnaire based on the frequency of nasal symptoms was the most sensitive tool used to diagnose sinonasal disease (minimum specificity, 0.90). Reproducibility testing in a separate cohort of 63 participants (41 chronic sinonasal disease with asthma, 22 chronic sinonasal disease without asthma) showed a concordance correlation coefficient of 0.91 (95% CI, 0.85 to 0.94) when this questionnaire was limited to five items (ie, excluding a question on smell). This five-item questionnaire had a sensitivity of 0.90 (95% CI, 0.77 to 0.97), a specificity of 0.94 (95% CI, 0.71 to 1.00), and an area under the receiver operating characteristic curve of 0.97 (95% CI, 0.93 to 1.0). Sinus CT scans and nasal endoscopy lacked sensitivity for use in the diagnosis of chronic sinonasal disease. CONCLUSIONS: We have developed a sensitive, specific, and reproducible instrument to screen for chronic sinonasal disease. Validation studies of this five-item questionnaire are needed, including in patients with asthma.
Authors: R O Crapo; R Casaburi; A L Coates; P L Enright; J L Hankinson; C G Irvin; N R MacIntyre; R T McKay; J S Wanger; S D Anderson; D W Cockcroft; J E Fish; P J Sterk Journal: Am J Respir Crit Care Med Date: 2000-01 Impact factor: 21.405
Authors: Raymond G Slavin; Sheldon L Spector; I Leonard Bernstein; Michael A Kaliner; David W Kennedy; Frank S Virant; Ellen R Wald; David A Khan; Joann Blessing-Moore; David M Lang; Richard A Nicklas; John J Oppenheimer; Jay M Portnoy; Diane E Schuller; Stephen A Tilles; Larry Borish; Robert A Nathan; Brian A Smart; Mark L Vandewalker Journal: J Allergy Clin Immunol Date: 2005-12 Impact factor: 10.793
Authors: A ten Brinke; P J Sterk; A A M Masclee; P Spinhoven; J T Schmidt; A H Zwinderman; K F Rabe; E H Bel Journal: Eur Respir J Date: 2005-11 Impact factor: 16.671
Authors: Kevin R Flaherty; Talmadge E King; Ganesh Raghu; Joseph P Lynch; Thomas V Colby; William D Travis; Barry H Gross; Ella A Kazerooni; Galen B Toews; Qi Long; Susan Murray; Vibha N Lama; Steven E Gay; Fernando J Martinez Journal: Am J Respir Crit Care Med Date: 2004-07-15 Impact factor: 21.405
Authors: Janet T Holbrook; Elizabeth A Sugar; Robert H Brown; Lea T Drye; Charles G Irvin; Alan R Schwartz; Robert S Tepper; Robert A Wise; Razan Z Yasin; Michael F Busk Journal: Ann Am Thorac Soc Date: 2016-11
Authors: Stephen C Lazarus; Jerry A Krishnan; Tonya S King; Jason E Lang; Kathryn V Blake; Ronina Covar; Njira Lugogo; Sally Wenzel; Vernon M Chinchilli; David T Mauger; Anne-Marie Dyer; Homer A Boushey; John V Fahy; Prescott G Woodruff; Leonard B Bacharier; Michael D Cabana; Juan C Cardet; Mario Castro; James Chmiel; Loren Denlinger; Emily DiMango; Anne M Fitzpatrick; Deborah Gentile; Annette Hastie; Fernando Holguin; Elliot Israel; Daniel Jackson; Monica Kraft; Craig LaForce; Robert F Lemanske; Fernando D Martinez; Wendy Moore; Wayne J Morgan; James N Moy; Ross Myers; Stephen P Peters; Wanda Phipatanakul; Jacqueline A Pongracic; Loretta Que; Kristie Ross; Lewis Smith; Stanley J Szefler; Michael E Wechsler; Christine A Sorkness Journal: N Engl J Med Date: 2019-05-19 Impact factor: 91.245
Authors: Ubong Peters; Meenakumari Subramanian; David G Chapman; David A Kaminsky; Charles G Irvin; Robert A Wise; Gwen S Skloot; Jason H T Bates; Anne E Dixon Journal: Respirology Date: 2019-01-29 Impact factor: 6.424
Authors: Anne E Dixon; Mario Castro; Rubin I Cohen; Lynn B Gerald; Janet T Holbrook; Charles G Irvin; Shyam Mohapatra; Stephen P Peters; Sobharani Rayapudi; Elizabeth A Sugar; Robert A Wise Journal: J Allergy Clin Immunol Date: 2015-05-08 Impact factor: 10.793
Authors: Anne E Dixon; Mario Castro; Lynn B Gerald; Janet T Holbrook; Robert J Henderson; Thomas B Casale; Charles G Irvin; Kendall Black; Robert A Wise; Elizabeth A Sugar Journal: J Allergy Clin Immunol Pract Date: 2017-04-07
Authors: Junfang Jiao; Tonya S King; Matthew McKenzie; Leonard B Bacharier; Anne E Dixon; Christopher D Codispoti; Ryan M Dunn; Nicole L Grossman; Njira L Lugogo; Sima K Ramratnam; Russell S Traister; Michael E Wechsler; Mario Castro Journal: J Allergy Clin Immunol Date: 2016-03-11 Impact factor: 10.793
Authors: Milena Hristova; Aida Habibovic; Carmen Veith; Yvonne M W Janssen-Heininger; Anne E Dixon; Miklos Geiszt; Albert van der Vliet Journal: J Allergy Clin Immunol Date: 2015-11-17 Impact factor: 10.793
Authors: Anne E Dixon; Mario Castro; Rubin I Cohen; Lynn B Gerald; Janet T Holbrook; Charles G Irvin; Shyam Mohapatra; Stephen P Peters; Sobharani Rayapudi; Elizabeth A Sugar; Robert A Wise Journal: J Allergy Clin Immunol Date: 2014-08-28 Impact factor: 10.793
Authors: Wayne D Hsueh; David B Conley; Haena Kim; Stephanie Shintani-Smith; Rakesh K Chandra; Robert C Kern; Bruce K Tan Journal: Int Forum Allergy Rhinol Date: 2012-11-05 Impact factor: 3.858